Ann: Letter to Shareholders from the Board of Directors, page-4

I am very interested to hear more about the new drug candidate the team have their eye on. There seems to be a viable strategy in place where the economics work. Fingers crossed the April AGM is more of a formality where current BOD are kept in place and able to realise this vision.

I certainly don't want to judge PVL unfairly but they haven't exactly endeared themselves to the existing shareholder base and their lack of strategy / vision / experience to manage PER is extremely telling. However, I do feel that we should respect them as a majority shareholder of the company (Comical Ali obviously excluded from that sentiment!).

Exciting times ahead!